EPHB2 and neoplasm: From these data, along with in vitro and in vivo results [23], we conclude that EphB2 is moderately expressed and might behave as a tumor suppressor in normal and benign mammary tissues, despite being overexpressed in later stages, when it is associated with invasiveness and metastasis.